StockData
Zymeworks Inc. logo

Zymeworks Inc. (ZYME) stock

ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30667% above fair value
$26.04+0.20 (+0.77%)

Close on Nov 18, 2026Market cap $1.85BP/E –Yield –

Zymeworks shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Zymeworks's shares outstanding was 73M at Jun 30, 2026. For fiscal 2025 it was 75M, down 0.6% from the year before. The highest annual figure on record is 76M in fiscal 2024.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202575M-0.6%
FY2024Dec 31, 202476M+10.2%
FY2023Dec 31, 202369M+5.5%
FY2022Dec 31, 202265M+25.2%
FY2021Dec 31, 202152M+3.5%
FY2020Dec 31, 202050M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202673M-5.7%
Q1 FY2026Mar 31, 202675M-0.7%
Q4 FY2025Dec 31, 202575M+0.8%
Q3 FY2025Sep 30, 202576M-0.5%
Q2 FY2025Jun 30, 202577M+1.3%
Q1 FY2025Mar 31, 202575M-1.3%
Q4 FY2024Dec 31, 202475M+5.5%
Q3 FY2024Sep 30, 202476M+7.9%
Q2 FY2024Jun 30, 202476M+13.5%
Q1 FY2024Mar 31, 202476M+14.2%
Q4 FY2023Dec 31, 202371M+6.1%
Q3 FY2023Sep 30, 202371M+6.2%
Q2 FY2023Jun 30, 202367M+1.4%
Q1 FY2023Mar 31, 202367M+8.7%
Q4 FY2022Dec 31, 202267M+28.0%
Q3 FY2022Sep 30, 202266M+27.3%
Q2 FY2022Jun 30, 202266M–
Q1 FY2022Mar 31, 202261M–
Q4 FY2021Dec 31, 202152M–
Q3 FY2021Sep 30, 202152M–

More Zymeworks figures

See a number that looks wrong?